Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

U.S. corporate junk-bond spread narrows, lowest since 2007

06/17/2021 | 02:32pm EDT
Floor traders work space is seen on the trading floor after the closing bell, following traders positive for Coronavirus disease (COVID-19), at the NYSE in New York

CHICAGO (Reuters) - The yield spread between junk-rated corporate bonds and U.S. Treasuries tightened further late on Wednesday, falling to its lowest level in more than a decade as yield-hungry investors snapped up risky debt.

On the ICE BofA U.S. High Yield Index, a commonly used benchmark for the junk bond market, the spread dipped to 312 basis points, the lowest since July 2007. That was down from the prior day's 317 basis points, which was the lowest since October 2018.

The narrowing of spreads, which refers to the interest rate premium investors demand to hold corporate debt over safer Treasuries, comes as low-yielding government debt is driving money into riskier securities.

The yield spread on the ICE BofA U.S Investment Grade Index has also contracted, reaching its lowest level since February 2007 this week.

The last time junk-bond spreads were this low was in July 2007, not long before the global financial crisis totally upended the perception of risk, catapulting the high-yield premium over Treasuries above 2,000 basis points by December 2008 and the investment-grade corporate bond premium above 600 basis points.

(Reporting By Karen Pierog; Editing by Alden Bentley and Catherine Evans)

ę Reuters 2021
Latest news "Economy & Forex"
12:21pBrazil frost triggers record coffee options trade
12:19pU.S. solar company files request to extend Trump-era solar tariffs
12:18pGsk - submitted a bla to u.s. fda for priorix, seeking approval for use in active immunization against infection by measles, mumps and rubella (mmr)
12:17pUK'S JOHNSON SAYS : We need to get the travel industry moving again
12:17pGsk - files for licensure of mmr vaccine in u.s.
12:14pOil slumps 4% on concerns over demand and OPEC supply boost
12:14pU.S. labor revival in doubt as Delta raises worries about 'back to school'
12:11pGerman business group says ECB rates policy threatens euro
12:02pSTRATA IDENTITY : Named Top Cybersecurity Startup for 2021 in Black Unicorn Awards
11:59aEssar Oil UK appoints new CEO - statement
Latest news "Economy & Forex"